UK pharmaceutical giant AstraZeneca PLC on Friday said that it was abandoning plans to build a ￡450 million (US$557.5 million) vaccine plant, a major blow to the Labour Party government’s plans to revive a sluggish economy.
“Following protracted discussions with the government, we are no longer pursuing our planned investment” for Speke in Liverpool, northwest England, a company spokesperson said.
The company cited “timing” issues and a “reduction” in the public subsidies offered by the Labour government compared with its Conservative predecessor.
Photo: REUTERS
A source close to the issue said that British Prime Minister Keir Starmer’s government, elected in July last year, was proposing ￡40 million in subsidies compared with the ￡90 million offered previously.
A government spokesperson said that “a change in the make-up of the investment originally proposed by AstraZeneca led to a reduced government grant offer being put forward.”
“All government grant funding has to demonstrate value for the taxpayer and unfortunately, despite extensive work from government officials, it has not been possible to achieve a solution,” the spokesperson added.
The group already has a factory on the site, which would not be affected by the decision and would continue to produce flu vaccines.
The UK government did not immediately respond when asked for comment.
However, media reports called it a snub to British Chancellor of the Exchequer Rachel Reeves, who has tried in recent weeks to reassure companies worried about tax rises on employers announced at the end of October last year.
Reeves, who has said for months that growth is her priority, on Wednesday outlined a recovery plan whose flagship measure was the government’s approval of a third runway at Heathrow, the largest airport in the UK and Europe.
She also announced relaxations of planning rules and deregulation measures to boost investment, as well as backing several investment projects to make the Oxford-Cambridge axis a “European Silicon Valley.”
Having already stalled in the third quarter and then fallen in October, the UK’s GDP rebounded by a less-than-expected 0.1 percent in November last year. However, the IMF mid last month revised upward its growth forecast for the country this year to 1.6 percent.
The Society of Chemical Industry called AstraZeneca’s decision a “real concern for industry,” because it sent “out the wrong message at a time government is shaping its new industrial strategy.”
“If life sciences are going to be a major pillar of the UK’s new industrial strategy, then the UK needs to make some bold steps forward to ensure it is competitive for life sciences investments,” said the society’s chief executive, Sharon Todd.
CHIP HANG-UP: Surging memorychip prices would deal a blow to smartphone sales this year, potentially hindering one of MediaTek’s biggest sources of revenue MediaTek Inc (聯發科), the world’s biggest smartphone chip designer, yesterday said its new artificial intelligence (AI) chips used in data centers are to account for 20 percent of its total revenue next year, as cloud service providers race to deploy AI infrastructure to meet voracious demand. MediaTek is believed to be developing tensor processing units for Google, which are used in AI applications. While it did not confirm such reports, MediaTek said its new application-specific IC (ASIC) business would be a new growth engine for the company. It again hiked its forecast for the addressable ASIC market to US$70 billion by 2028, compared
Motorists ride past a mural along a street in Varanasi, India, yesterday.
MediaTek Inc (聯發科), the world’s biggest smartphone chip supplier, yesterday said it plans to double investment in data center-related technologies, including advanced packaging and high-speed interconnect technologies, to broaden the new business’ customer and service portfolios. The chip designer is redirecting its resources to data centers, mainly designing application-specific integrated circuits (ASIC) with artificial intelligence (AI) capabilities for cloud service providers. The data center business is forecast to lead growth in the next three years and become the company’s second-biggest revenue source, replacing chips used in smart devices, MediaTek president Joe Chen (陳冠州) told a media event in Taipei. “Three or four years
AT HIGH CAPACITY: Three-month order visibility on stable customer demand would push factory utilization to between 80 and 85 percent, Vanguard’s president said Foundry service provider Vanguard International Semiconductor Corp (世界先進) yesterday said it is unable to fully satisfy surging demand for chips used in artificial intelligence (AI) servers and data centers, amid an AI infrastructure investment boom that is crowding out production of less advanced chips. Vanguard is facing an “undersupply of chips” made using mature process technologies, due to strong demand for AI products and improving demand from customers in the commercial, industrial and auto sectors, which are digesting excess inventory to a healthier level, company chairman Fang Leuh (方略) told a virtual investors’ conference. However, Vanguard gave a more conservative view on
RSS